Vaccine delivery is a critical aspect of immunization programs, focusing on methods to administer vaccines effectively and safely to target populations. Traditional vaccine delivery methods include intramuscular or subcutaneous injections, widely used for routine immunizations. More recently, advances in needle-free technologies, such as jet injectors and microneedle patches, aim to improve vaccine accessibility and reduce pain associated with injections. Oral vaccines, administered through the mouth, offer a convenient and non-invasive alternative, particularly advantageous for mass vaccination campaigns. Intranasal delivery, using nasal sprays or droplets, targets the mucosal immune system, providing protection at the site of pathogen entry. Cold chain management is crucial for preserving vaccine efficacy during transportation and storage. Innovations like heat-stable vaccines and controlled-release formulations aim to mitigate challenges associated with cold chain requirements, especially in resource-limited settings. The COVID-19 pandemic has witnessed the rapid deployment of novel vaccine delivery approaches, including mRNA vaccines delivered through intramuscular injections and viral vector vaccines. These developments underscore the dynamic nature of vaccine delivery strategies, emphasizing accessibility, ease of administration, and adaptability to diverse healthcare settings. Ongoing research explores innovative delivery technologies to enhance vaccine coverage and address global health challenges.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India